A

Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540

Watchlist Manager
Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
Watchlist
Price: 9 020 KRW 0.89% Market Closed
Market Cap: 102.5B KRW

Intrinsic Value

The intrinsic value of one Ahn-Gook Pharmaceutical Co Ltd stock under the Base Case scenario is 15 734.24 KRW. Compared to the current market price of 9 020 KRW, Ahn-Gook Pharmaceutical Co Ltd is Undervalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
15 734.24 KRW
Undervaluation 43%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation History
Ahn-Gook Pharmaceutical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Ahn-Gook Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Ahn-Gook Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Ahn-Gook Pharmaceutical Co Ltd.

Explain Valuation
Compare Ahn-Gook Pharmaceutical Co Ltd to

Fundamental Analysis

Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540
KR
Pharmaceuticals
Market Cap
102.5B KRW
IPO
Jun 15, 2000
KR
Pharmaceuticals
Market Cap
102.5B KRW
IPO
Jun 15, 2000
Price
â‚©
â‚©
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Ahn-Gook Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ahn-Gook Pharmaceutical Co Ltd

Current Assets 135.6B
Cash & Short-Term Investments 48.8B
Receivables 42.8B
Other Current Assets 44B
Non-Current Assets 166.2B
Long-Term Investments 39.2B
PP&E 119.1B
Intangibles 3.6B
Other Non-Current Assets 4.4B
Current Liabilities 76.8B
Accounts Payable 11.8B
Accrued Liabilities 12B
Short-Term Debt 27.3B
Other Current Liabilities 25.7B
Non-Current Liabilities 60B
Long-Term Debt 50.3B
Other Non-Current Liabilities 9.7B
Efficiency

Free Cash Flow Analysis
Ahn-Gook Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ahn-Gook Pharmaceutical Co Ltd

Revenue
290.8B KRW
Cost of Revenue
-106.1B KRW
Gross Profit
184.7B KRW
Operating Expenses
-171.9B KRW
Operating Income
12.8B KRW
Other Expenses
-6.7B KRW
Net Income
6.1B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Ahn-Gook Pharmaceutical Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
ROIC is Increasing
Operating Margin is Increasing
46/100
Profitability
Score

Ahn-Gook Pharmaceutical Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Ahn-Gook Pharmaceutical Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
50/100
Solvency
Score

Ahn-Gook Pharmaceutical Co Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Ahn-Gook Pharmaceutical Co Ltd

There are no price targets for Ahn-Gook Pharmaceutical Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Ahn-Gook Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Ahn-Gook Pharmaceutical Co Ltd stock?

The intrinsic value of one Ahn-Gook Pharmaceutical Co Ltd stock under the Base Case scenario is 15 734.24 KRW.

Is Ahn-Gook Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 9 020 KRW, Ahn-Gook Pharmaceutical Co Ltd is Undervalued by 43%.

Back to Top